Search results

Evidence-based recommendations on sofosbuvir (Sovaldi) for treating some types of chronic hepatitis C (HCV)

Result type

Technology appraisal guidance

Published

25 February 2015

Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

21 February 2018

Evidence-based recommendations on ledipasvir–sofosbuvir (Harvoni) for treating some types (genotypes) of chronic hepatitis C

Result type

Technology appraisal guidance

Published

25 November 2015

Evidence-based recommendations on sofosbuvir–velpatasvir (Epclusa) for treating chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

25 January 2017

Evidence-based recommendations on elbasvir–grazoprevir (Zepatier) for treating genotype 1 or 4 chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

26 October 2016

Evidence-based recommendations on ombitasvir–paritaprevir–ritonavir (also known as Viekirax) with or without dasabuvir (also known as Exviera) for adults with some types (called genotypes) of chronic hepatitis C.

Result type

Technology appraisal guidance

Published

25 November 2015

Evidence-based recommendations on elafibranor (Iqirvo) for previously treated primary biliary cholangitis in adults.

Result type

Technology appraisal guidance

Published

14 November 2024

Evidence-based recommendations on obeticholic acid (Ocaliva) for treating primary biliary cholangitis in adults.

Result type

Technology appraisal guidance

Published

26 April 2017

interventions delivered remotely (that is, by telephone, text message, phone and tablet apps or the internet)? How does this vary among...